HR 19034
Alternative Names: HR-19034Latest Information Update: 12 Jan 2024
At a glance
- Originator Jiangsu Hengrui Medicine Co.
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No